Blog

Sep 8, 2024, 09:00

Joe Y. Chang: Join the WCLC brain metastases discussion

Joe Y. Chang, Director of Stereotactic Ablative Radiotherapy Program at MD Anderson Cancer Center, shared a post on X:

“Brain metastases used to be an ’emergency.’ Stereotactic radiosurgery (SRS) has replaced whole brain radiation therapy (WBRT) for lesions up to 10. In the era of newer generation tyrosine kinase inhibitors (TKIs), there is a need to balance local control (LC) versus the toxicities of brain radiation therapy (RT). We need both cutting-edge technology and novel biology. We welcome you to join our WCLC brain metastases discussion on September 9, 2024.”

Joe Y. Chang

Source: Joe Y. Chang/X

brain metastases cancer Joe Y Chang MD Anderson Cancer Center OncoDaily Oncology radiation therapy stereotactic radiosurgery WCLC whole brain radiation therapy

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology